EUVIMEDEUVIMED entdecken
Crossref

Astragaloside IV Inhibits Lung Injury and Fibrosis Induced by PM2.5 by Targeting RUNX1 Through miR-362-3p

Hao Tian, Yan Zhang, Wei Li, GenTan Xie, JunJing Wu, Jing Liu

Molecular Biotechnology · 2025

DOI: 10.1007/s12033-024-01320-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Hao Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Yantai Qishan Hospital, Yantai City, 264000, Shandong Province, China. Hauptthemen laut MEDLINE: MicroRNAs, Saponins, Triterpenes, Particulate Matter. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To discover the molecular mechanism of Astragaloside IV (AS IV) in PM2.5-induced lung injury and pulmonary fibrosis (PF). A lung injury rat model was induced by PM2.5 and injected intraperitoneally with AS IV. Lungs were harvested to evaluate lung tissue injury and apoptosis. Rat alveolar epithelial cells L2 were exposed to PM2.5 and treated with AS IV. After cellular transfection, cell proliferation, LDH production, and apoptosis were measured. In both models, inflammatory factors and fibrotic indices were measured by ELISA and Western blot. miR-362-3p and RUNX1 interplay was explored and confirmed. Administration of AS IV attenuated PM2.5-induced lung tissue injury, inflammation, apoptosis, and PF in rats. AS IV enhanced proliferation and reduced LDH release, apoptosis, inflammation, and PF in PM2.5-treated L2 cells. MiR-362-3p upregulation improved PM2.5-induced L2 cell injury. AS IV improved PM2.5-induced lung injury by upregulating miR-362-3p. miR-362-3p had an inhibition effect on RUNX1 expression. RUNX1 upregulation weakened the therapeutic effect of AS IV on PM2.5-induced alveolar epithelial cell injury. AS IV inhibits lung injury and PF induced by PM2.5 by targeting RUNX1 through upregulation of miR-362-3p.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSaponinsTriterpenesParticulate MatterLung InjuryCore Binding Factor Alpha 2 SubunitPulmonary FibrosisAnimalsRatsMaleApoptosisRats, Sprague-DawleyCell LineAlveolar Epithelial CellsCell ProliferationDisease Models, Animal

Stichwörter der Autor:innen

Astragaloside IVFibrosisLung injuryMiR-362-3pRUNX1

Substanzen

MicroRNAsastragaloside ASaponinsTriterpenesParticulate MatterCore Binding Factor Alpha 2 Subunit

Autor:innen und Institutionen

  • Department of Pharmacy, Yantai Qishan Hospital, Yantai City, 264000, Shandong Province, China.
  • Binzhou Vocational College, Binzhou City, 256603, Shandong Province, China.
  • Department of Otorhinolaryngology, Zibo Central Hospital, Zibo City, 255020, Shandong Province, China.
  • Department of Intravenous Drug Dispensing, Zibo Central Hospital, No. 54, Gongqingtuan West Road, Zhangdian District, Zibo City, 255020, Shandong Province, China. liu_jing_50@hotmail.com.

Zitieren

APA

Tian, H., Zhang, Y., Li, W., Xie, G., Wu, J., & Liu, J. (2025). Astragaloside IV Inhibits Lung Injury and Fibrosis Induced by PM2.5 by Targeting RUNX1 Through miR-362-3p. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01320-5

Vancouver

Tian H, Zhang Y, Li W, Xie G, Wu J, Liu J. Astragaloside IV Inhibits Lung Injury and Fibrosis Induced by PM2.5 by Targeting RUNX1 Through miR-362-3p. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01320-5

BibTeX
@article{Tian2025,
  author = {Tian, Hao and Zhang, Yan and Li, Wei and Xie, GenTan and Wu, JunJing and Liu, Jing},
  title = {Astragaloside IV Inhibits Lung Injury and Fibrosis Induced by PM2.5 by Targeting RUNX1 Through miR-362-3p},
  journal = {Molecular Biotechnology},
  year = {2025},
  doi = {10.1007/s12033-024-01320-5}
}
Kostenlos starten →